Brief: Pixium Vision Reports ESGO's Conversion Of 160 Ornan2022
03/04/2023 06:23
April 3 (Reuters) - Pixium Vision SA ALPIX.PA :
* COMMUNICATION FOLLOWING ANNOUNCEMENT OF FDA BREAKTHROUGH
DEVICE
DESIGNATION FOR PRIMA SYSTEM IN DRY AMD
* CONVERSION OF 160 ORNAN2022 BY ESGO WITH INTENTION TO
PURSUE
CONTROLLED TRADING OF SHARES
* COST REDUCTION MEASURES IMPLEMENTED POTENTIALLY EXTENDING
CASH
RUNWAY BEYOND END OF Q2 2023
* AFTER CONVERSION, SHARE CAPITAL OF COMPANY AMOUNTS TO EUR
2,980,403.72 REPRESENTED BY 148,664,926 SHARES
Source text for Eikon: ID:nGNX9NdBtp
Further company coverage: ALPIX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48587696600;))
Recent news on Pixium Vision SA
See all newsBrief: Pixium Vision SA Says Paris Commercial Court Postponed Decision On Takeover Offer Filed On Nov 20, 2023
Brief: Pixium Vision: opening of judicial liquidation proceedings has been postponed to later date
Brief: Pixium Vision Announces Decision About Adoption Of Sale Plan, Opening Of Judicial Liquidation Proceedings Planned For Jan 16, 2024
Brief: Pixium Vision SA Announces Conversion Of Safeguard Proceedings Into Receivership
Brief: Pixium Vision Announces Tender Process For Purpose Of Finding Buyers To Acquire Company's Business Will Be Published Tomorrow